{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Titusville",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71064",
      "recalling_firm": "Janssen Pharmaceuticals, Inc.",
      "address_1": "1125 Trenton-Harbourton Rd",
      "address_2": "N/A",
      "postal_code": "08560-1503",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide and Canada",
      "recall_number": "D-1063-2015",
      "product_description": "Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only, Jointly Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674 and NV Organon, Oss, The Netherlands, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560, New Jersey, NDC 50458-0196-15.",
      "product_quantity": "16,861 cartons/6 blister units (28 tablets) each",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20150429",
      "center_classification_date": "20150511",
      "termination_date": "20180713",
      "report_date": "20150520",
      "code_info": "Lot # 13CM724, Exp.09/15 (US)  Lot # (L) 13DM732, Exp. 09/15 (Canada)",
      "more_code_info": ""
    }
  ]
}